HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.

AbstractINTRODUCTION:
The ATN framework provides an in vivo diagnosis of Alzheimer's disease (AD) using cerebrospinal fluid (CSF) biomarkers of pathologic amyloid plaques (A), tangles (T), and neurodegeneration (N). ATN is rarely evaluated in pathologically confirmed patients and its poor sensitivity to suspected non-Alzheimer's pathophysiologies (SNAP), including frontotemporal lobar degeneration (FTLD), leads to misdiagnoses. We compared accuracy of ATN (ATNTAU ) using CSF total tau (t-tau) to a modified strategy (ATNNfL ) using CSF neurofilament light chain (NfL) in an autopsy cohort.
METHODS:
ATNTAU and ATNNfL were trained in an independent sample and validated in autopsy-confirmed AD (n = 67) and FTLD (n = 27).
RESULTS:
ATNNfL more accurately identified FTLD as SNAP (sensitivity = 0.93, specificity = 0.94) than ATNTAU (sensitivity = 0.44, specificity = 0.97), even in cases with co-occurring AD and FTLD. ATNNfL misclassified fewer AD and FTLD as "Normal" (2%) than ATNTAU (14%).
DISCUSSION:
ATNNfL is a promising diagnostic strategy that may accurately identify both AD and FTLD, even when pathologies co-occur.
AuthorsKatheryn A Q Cousins, Jeffrey S Phillips, David J Irwin, Edward B Lee, David A Wolk, Leslie M Shaw, Henrik Zetterberg, Kaj Blennow, Sarah E Burke, Nikolas G Kinney, Garrett S Gibbons, Corey T McMillan, John Q Trojanowski, Murray Grossman
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement) Vol. 17 Issue 5 Pg. 822-830 (05 2021) ISSN: 1552-5279 [Electronic] United States
PMID33226735 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2020 the Alzheimer's Association.
Chemical References
  • Biomarkers
  • Neurofilament Proteins
  • neurofilament protein L
  • tau Proteins
Topics
  • Aged
  • Alzheimer Disease (pathology)
  • Autopsy (statistics & numerical data)
  • Biomarkers (cerebrospinal fluid)
  • Cohort Studies
  • Frontotemporal Lobar Degeneration (diagnosis, pathology)
  • Humans
  • Middle Aged
  • Neurofilament Proteins (cerebrospinal fluid)
  • Plaque, Amyloid (cerebrospinal fluid)
  • tau Proteins (cerebrospinal fluid)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: